This webinar explores how model-informed CMC development can improve the design and manufacturing of amorphous solid dispersions (ASDs) using hot melt extrusion (HME) and continuous manufacturing technologies. The session highlights how poorly soluble drug molecules—which represent the majority of modern APIs, can benefit from ASD formulations that enhance bioavailability, stability, and overall product performance.
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
Pharmatech Associates, Inc. 9110 Alcosta Blvd. STE H #601 San Ramon CA 94583
